INNV Stock Overview
Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for INNV from our risk checks.
InnovAge Holding Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.70 |
| 52 Week High | US$6.69 |
| 52 Week Low | US$3.52 |
| Beta | 0.38 |
| 11 Month Change | -19.24% |
| 3 Month Change | -22.57% |
| 1 Year Change | -15.16% |
| 33 Year Change | -41.18% |
| 5 Year Change | n/a |
| Change since IPO | -80.58% |
Recent News & Updates
Recent updates
Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues
Nov 07
Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?
Aug 20InnovAge Holding Corp.'s (NASDAQ:INNV) Shares Leap 30% Yet They're Still Not Telling The Full Story
Jun 28Sentiment Still Eluding InnovAge Holding Corp. (NASDAQ:INNV)
May 07InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?
Mar 15Market Still Lacking Some Conviction On InnovAge Holding Corp. (NASDAQ:INNV)
Jan 06InnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 73% Above Its Share Price
Aug 10Cautious Investors Not Rewarding InnovAge Holding Corp.'s (NASDAQ:INNV) Performance Completely
Jun 08InnovAge GAAP EPS of -$0.09 misses by $0.06, revenue of $172.86M misses by $1.11M
Sep 13InnovAge names Richard Feifer as chief medical officer
Aug 17InnovAge Holding (NASDAQ:INNV) Could Be Struggling To Allocate Capital
Jul 27Earnings Miss: InnovAge Holding Corp. Missed EPS And Analysts Are Revising Their Forecasts
May 12Here's What's Concerning About InnovAge Holding's (NASDAQ:INNV) Returns On Capital
Apr 14Is There An Opportunity With InnovAge Holding Corp.'s (NASDAQ:INNV) 30% Undervaluation?
Mar 24InnovAge Pursues Compliance As Precursor To Post-Pandemic Growth
Mar 19InnovAge Holding's (NASDAQ:INNV) Robust Earnings Are Supported By Other Strong Factors
Nov 16Are Investors Undervaluing InnovAge Holding Corp. (NASDAQ:INNV) By 48%?
Jul 28Shareholder Returns
| INNV | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -14.1% | -1.2% | -1.0% |
| 1Y | -15.2% | 2.5% | 30.3% |
Return vs Industry: INNV underperformed the US Healthcare industry which returned 1.1% over the past year.
Return vs Market: INNV underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| INNV volatility | |
|---|---|
| INNV Average Weekly Movement | 6.2% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: INNV has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: INNV's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 2,350 | Patrick Blair | www.innovage.com |
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
InnovAge Holding Corp. Fundamentals Summary
| INNV fundamental statistics | |
|---|---|
| Market cap | US$647.48m |
| Earnings (TTM) | -US$15.96m |
| Revenue (TTM) | US$786.51m |
0.8x
P/S Ratio-39.9x
P/E RatioIs INNV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INNV income statement (TTM) | |
|---|---|
| Revenue | US$786.51m |
| Cost of Revenue | US$236.92m |
| Gross Profit | US$549.59m |
| Other Expenses | US$565.56m |
| Earnings | -US$15.96m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 69.88% |
| Net Profit Margin | -2.03% |
| Debt/Equity Ratio | 22.2% |
How did INNV perform over the long term?
See historical performance and comparison